BackEliem Therapeutics Overview
Eliem Therapeutics Inc

Eliem Therapeutics Discounted Cash Flow

DCF Analysis for ELYM.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$3.44

Current Fair Value

$3.44
32.7% Downside

Overvalued by 32.7% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading